APA (7th ed.) Citation

Shibutani, M., Tanda, H., Kasashima, H., Fukuoka, T., Kashiwagi, S., & Maeda, K. Renal impairment as a risk factor for chemotherapy induced neutropenia in the treatment of trifluridine/thymidine phosphorylase inhibitor plus bevacizumab. Nature Portfolio.

Chicago Style (17th ed.) Citation

Shibutani, Masatsune, Hideki Tanda, Hiroaki Kasashima, Tatsunari Fukuoka, Shinichiro Kashiwagi, and Kiyoshi Maeda. Renal Impairment as a Risk Factor for Chemotherapy Induced Neutropenia in the Treatment of Trifluridine/thymidine Phosphorylase Inhibitor Plus Bevacizumab. Nature Portfolio.

MLA (9th ed.) Citation

Shibutani, Masatsune, et al. Renal Impairment as a Risk Factor for Chemotherapy Induced Neutropenia in the Treatment of Trifluridine/thymidine Phosphorylase Inhibitor Plus Bevacizumab. Nature Portfolio.